Companies: 10,795·Total market cap: $144.5T
aTyr Pharma, Inc.

aTyr Pharma, Inc.

ATYRNASDAQHealthcare● Active
$0.47
+$0.03(+7.22%)
Market Cap$46476269
P/E Ratio
52W High$7.29
52W Low$0.395
Overview

aTyr Pharma, Inc.(ATYR)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ATYR · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.19M$0.23M$0.35M$10.39M$0.00M
Cost of Revenue$1.55M$0.00M$0.00M$1.70M$1.30M
Gross Profit($1.36M)$0.23M$0.35M$8.69M($1.30M)
Gross Margin %(computed)-717.37%100.00%100.00%83.68%
Operating Expenses
R&D Expenses$60.22M$54.37M$42.29M$42.81M$23.26M
G&A Expenses$17.60M$13.78M$12.98M$13.98M$10.75M
Total Operating Expenses$76.26M$68.15M$55.27M$55.09M$32.71M
Operating Income($77.63M)($67.91M)($54.92M)($46.40M)($34.02M)
Operating Margin %(computed)-446.79%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($74.12M)($64.02M)($50.40M)($45.34M)($33.78M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($74.12M)($64.02M)($50.39M)($45.34M)($33.77M)
Net Margin %(computed)-436.53%
Per Share & EBITDA
EPS (Basic)$-0.80$-0.86$-0.94$-1.60$-1.77
Wtd Avg Shares92.99M74.26M53.61M28.42M19.08M
EBITDA($76.07M)($66.37M)($52.18M)($44.71M)($32.47M)
EBITDA Margin %(computed)-430.47%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解aTyr Pharma, Inc.

关于aTyr Pharma, Inc.(ATYR)损益表

aTyr Pharma, Inc.(ATYR)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ATYR实现营收$0.00B,毛利润($0.00B)(毛利率-717.37%),净利润($0.07B)(净利率-39009.47%)。

常见问题

ATYR · 4 问

aTyr Pharma, Inc.(ATYR)2025财年营收为$0.00B,同比down19.1%。

ATYR revenueATYR salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09